OP Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32M Sell
14,773
-1,361
-8% -$339K 0.03% 332
2025
Q4
$3.89M Buy
16,134
+4
+0% +$1.02K 0.05% 286
2025
Q3
$4.42M Buy
16,130
+615
+4% +$168K 0.06% 266
2025
Q2
$4M Buy
15,515
+192
+1% +$45.8K 0.06% 272
2025
Q1
$3.43M Buy
+15,323
New +$3.58M 0.06% 281

Other funds holding RMD

OP Asset Management's RMD Position: Q1 2026 in Review

OP Asset Management reduced its ResMed (RMD) stake by 8.4% in Q1 2026, selling an estimated $339K and leaving 14,773 shares worth $3.32M. The position accounts for 0.03% of the portfolio, ranked #332.

OP Asset Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.42M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • OP Asset Management held 14,773 shares of ResMed worth $3.32M as of Q1 2026.
  • OP Asset Management sold 1,361 ResMed shares in Q1 2026, an estimated $339K.
  • ResMed made up 0.03% of OP Asset Management's portfolio in Q1 2026, its #332 holding.
  • OP Asset Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • OP Asset Management's ResMed position peaked at $4.42M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.